Austin Area Society of Health-System Pharmacists

   
 
 

Home spacer
About AASHP spacer
Officers spacer
Newsletters spacer
Meetings spacer
Photos spacer
Links spacer
Membership spacer
Contact Us

 

Wednesday, February 12, 2014
AASHP Dinner Meeting 

Date Wednesday, February 12, 2014 
Time  
6:00-6:30 pm   Registration & Dinner
6:30-7:05 pm   Welcome/Introduction and Call to Action
7:05-8:05 pm   Interpretation of Drug Levels from a Viewpoint of a Toxicologist
8:05-8:20 pm   Q&A/Discussion

Place   Opal Divine's
Penn Field Location
3601 S. Congress K100
South Austin, TX 78704
(512) 707-0237

Click here for a map.

Topic and Speaker Risky Business: Infection Risk Associated with Therapeutic Agents Used for Inflammatory Bowel Disease and Rheumatoid Arthritis Management

Kathryn G. Merkel, PharmD, BCPS
Clinical Pharmacy Specialist – Pediatric Infectious Diseases
Dell Children’s Medical Center of Central Texas
Seton Family of Hospitals

This Activity-based continuing professional education program (0156-9999-14-123-L01-P and 0156-9999-14-123-L01-T) provides 1.0 contact hour (0.1 CEUs) of continuing pharmacy education for attending the live activity and completing an evaluation form.

Educational Objectives: After completing this live, knowledge-based activity, participants should be better able to: Learning Objectives (pharmacists):
  • Describe the types and mechanisms of immune responses
  • Explain the etiology and identify therapeutic agents used in the management of Inflammatory Bowel Disease and Rheumatoid Arthritis
  • Differentiate between infection risk associated with disease and therapeutic agents used for Inflammatory Bowel Disease and Rheumatoid Arthritis
  • Discuss the most current literature concerning the risk associated with therapeutic agents used for Inflammatory Bowel Disease and Rheumatoid Arthritis for serious or opportunistic infections
  • Educate patients, caregivers, and providers regarding special precautions and immunizations
Learning Objectives (technicians):
  • Identify types of immune responses
  • List therapeutic agents used in the management of Inflammatory Bowel Disease and Rheumatoid Arthritis
  • Discuss infection risk associated with disease and therapeutic agents used for Inflammatory Bowel Disease and Rheumatoid Arthritis
  • Describe education regarding special precautions and immunizations

Sponsor   AASHP

RSVP   Members of AASHP may attend this activity without charge. If you are not a current AASHP member, you may RSVP at this time but must visit www.tshp.org to join TSHP and AASHP before attending this meeting.

This meeting is closed.


Target Audience: Target audience: pharmacists, pharmacy technicians, pharmacy and pharmacy technician students planning on working in health-system pharmacies

The Texas Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This Activity-based continuing professional education program (0156-9999-14-123-L01-P & 0156-9999-14-123-L01-T) provides 1.0 contact hour (0.1 CEUs) of continuing pharmacy education. This program’s accreditation expires on February 6, 2015. To receive a Statement of Participation, a program evaluation form must be completed and turned in at the end of the program, as well as participation in the group discussions for the entire session.
 ACPE           Texas Society of Health-System Pharmacists
 
 
 

Copyright ©2017 Austin Area Society of Health-System Pharmacists of Health-System Pharmacists
PO Box 92341 • Austin, Texas 78709-2341

Questions about this site? Email the
 

spacer